Heterocycle-substituted proline dipeptides as potent VLA-4 antagonists

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Drug Discovery

Background:

• Integrin VLA-4 (very late antigen-4) is a key target in inflammatory diseases.
• Ester prodrugs often face challenges with cytochrome P450 3A4 (CYP3A4) time-dependent inhibition.
• Improving receptor off-rates is crucial for sustained therapeutic effects.

Purpose of the Study:

• To synthesize and evaluate N-linked tertiary amines and heteroarylamines at the 4-position of sulfonylated proline dipeptides.
• To enhance VLA-4 receptor off-rates and mitigate CYP3A4 time-dependent inhibition.
• To identify compounds with sustained receptor occupancy and improved pharmacokinetic profiles.

Main Methods:

• Synthesis of novel sulfonylated proline dipeptide derivatives.
• In vitro assays to measure VLA-4 receptor binding and off-rates.
• CYP3A4 inhibition assays to assess time-dependent inhibition.
• Pharmacokinetic studies to evaluate oral bioavailability and drug exposure.

Main Results:

• A series of N-linked amines were successfully synthesized and characterized.
• Several compounds demonstrated improved VLA-4 receptor off-rates compared to existing inhibitors.
• Compound 5j exhibited tight-binding characteristics and a prolonged receptor off-rate.
• Compound 5j achieved sustained receptor occupancy but displayed poor oral pharmacokinetics.

Conclusions:

• Modification of sulfonylated proline dipeptides can modulate VLA-4 receptor off-rates.
• Compound 5j represents a promising lead for sustained receptor occupancy, warranting further optimization for oral delivery.
• Addressing CYP3A4 inhibition and optimizing pharmacokinetics are critical for developing effective VLA-4 targeted therapeutics.